Mcgauley Thomas Insider Trades

Insider Trading History

Track insider trading activity for Mcgauley Thomas. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tenax Therapeutics
Tenax Therapeutics TENX
Interim CFO
Holding Value $539k 50,000 shares
Last Trade
Jan 30, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$626k 50,000 shares
$12.51
$10.77
Tenax Therapeutics
Tenax Therapeutics TENX
Interim CFO
Holding Value $53.9k 5,000 shares
Last Trade
Nov 17, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$36.2k 5,000 shares
$7.23
$10.77
Tenax Therapeutics
Tenax Therapeutics TENX
Interim CFO
Holding Value $21.5k 2,000 shares
Last Trade
Nov 17, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.7k 2,000 shares
$7.34
$10.77
Tenax Therapeutics
Tenax Therapeutics TENX
Interim CFO
Holding Value $10.8k 1,000 shares
Last Trade
Nov 17, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.35k 1,000 shares
$7.35
$10.77
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $58.8k 25,000 shares
Last Trade
Jun 19, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99.3k 25,000 shares
$3.97
$2.35
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $23.5k 10,000 shares
Last Trade
May 24, 2012 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23.5k 10,000 shares
$2.35
$2.35
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $23.5k 10,000 shares
Last Trade
May 23, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.4k 10,000 shares
$2.34
$2.35
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
May 25, 2010 Sale
$938 1,250 shares
$0.75
$2.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up